American Oncology Network Inc. Cash Flow Conversion Efficiency
American Oncology Network Inc. cash flow conversion efficiency. Based on the latest financial reports, American Oncology Network Inc. (AONC) has a cash flow conversion efficiency ratio of 0.110x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($11.93 Million) by net assets ($108.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see American Oncology Network Inc. stock valuation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of American Oncology Network Inc. (2020–2024)
Cash flow conversion efficiency of American Oncology Network Inc. from 2020 to 2024. This chart illustrates how American Oncology Network Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View American Oncology Network Inc. share price for real-time trading data and today's change.
American Oncology Network Inc. Cash Flow Conversion Ratio Explained
American Oncology Network Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
American Oncology Network Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of American Oncology Network Inc. ranked by their cash flow conversion efficiency. Review American Oncology Network Inc. (AONC) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenwu Energy Saving Co Ltd
SHE:000820
|
-0.017x |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
-0.325x |
|
Development Investment Construction JSC
VN:DIG
|
0.113x |
|
LINKBANCORP Inc
NASDAQ:LNKB
|
-0.023x |
|
Beihai Gofar Marine Biological Industry Co Ltd
SHG:600538
|
-0.015x |
|
Deva Holding AS
IS:DEVA
|
0.058x |
|
New Providence Acquisition Corp. III Class A Ordinary Shares
NASDAQ:NPAC
|
-0.001x |
|
Stalprodukt SA
WAR:STP
|
0.018x |
Annual Cash Flow Conversion Efficiency for American Oncology Network Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of American Oncology Network Inc. from 2020 to 2024. Also see AONC asset base for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $108.01 Million | $-4.94 Million | -0.046x | +82.14% |
| 2023-12-31 | $70.71 Million | $-18.12 Million | -0.256x | -134.22% |
| 2022-12-31 | $62.02 Million | $-6.78 Million | -0.109x | -1909.83% |
| 2021-12-31 | $226.04 Million | $-1.23 Million | -0.005x | -100.00% |
| 2020-12-31 | $24.17K | $37.24 Million | 1541.215x | -- |
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more